PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
14-Dec-2023 QPS Continues UPLC-HRMS Expansion Into Europe to Support Gene Therapy and Protein Drug Development Businesswire
14-Dec-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of National Instruments Corporation (NATI) on Behalf of Investors Businesswire
14-Dec-2023 ROME Publishes Landmark Nature Paper Revealing First High-Resolution Structure of LINE-1 Reverse Transcriptase (RT) for Drug Discovery Businesswire
14-Dec-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of LivePerson, Inc. (LPSN) on Behalf of Investors Businesswire
14-Dec-2023 US WorldMeds Announces FDA Approval of IWILFIN™ (eflornithine) to Strengthen Fight Against Aggressive Childhood Cancer Businesswire
14-Dec-2023 Biosimilars Pipeline Report: Comprehensive Analysis of Prolia & Xgeva Denosumab Candidates Emerges - ResearchAndMarkets.com Businesswire
14-Dec-2023 A new clinical study highlights efficiency in spine surgery of NextAR Spine, augmented reality surgical application Medacta Group SA
14-Dec-2023 A new clinical study highlights efficiency in spine surgery of NextAR Spine, augmented reality surgical application Medacta Group SA
14-Dec-2023 AscellaHealth Identifies Key Trends Worth Watching in 2024: Forecasts Robust Outlook for Specialty Pharmacy Industry Businesswire
14-Dec-2023 Rapid Growth at Attune Medical Spurs Strategic Hires and Expansion Businesswire
14-Dec-2023 Global Cell Culture Media Storage Containers Market Size, Share & Trends Analysis Report 2023-2030 - ResearchAndMarkets.com Businesswire
14-Dec-2023 USAntibiotics Expands Leadership Team with Appointment of Steven Lutz to Vice President of Strategic Accounts Businesswire
14-Dec-2023 XVIVO Announces a Write-Down Related to PrimECC of SEK 17 Million Not Affecting Cashflow or EBITDA AccessWire
14-Dec-2023 enVVeno Medical Posts Company Highlights and Materials from 2023 VEITH Symposium AccessWire
14-Dec-2023 Teva and Biolojic Design Announce Exclusive License Agreement for the Development of a Therapeutic Antibody for Atopic Dermatitis and Asthma Businesswire
14-Dec-2023 Maze Therapeutics Announces Initiation of Dosing in Phase 1 Trial Evaluating MZE829, a Novel Oral APOL1 Inhibitor, as a Potential Treatment for APOL1 Kidney Disease Businesswire
14-Dec-2023 Parse Biosciences Closes $50 Million of Financing to Fuel Continued Worldwide Growth Businesswire
14-Dec-2023 CinFina Pharma, a CinRx Portfolio Company, Introduces Scientific Advisory Board with Deep Metabolic Expertise Businesswire
14-Dec-2023 Au Pair USA: Transforming Lives Through Cultural Exchange and Volunteerism AccessWire
14-Dec-2023 Dr. Reddy’s becomes first Indian pharma company to debut on the Dow Jones Sustainability World Index Businesswire